Kenya

Kenya receives first batch of J&J Vaccines

Format
News and Press Release
Source
Posted
Originally published
Origin
View original

Addis Ababa, 3 September 2021 (ECA) - Kenya on Friday September 3, received its first consignment of 141,600 doses of Johnson and Johnson (J&J) vaccines purchased through the Africa Vaccine Acquisition Trust Mechanism (AVAT) and will receive another consignment 248,000 doses next week.

This is the first batch of the 13.3 million Johnson and Johnson vaccine doses that the Kenyan government has purchased under the African Union pooled procurement mechanism. The country expects to have one million doses of Johnson and Johnson vaccines coming in every month.

While receiving the vaccines at Jomo Kenyatta International Airport, Dr. Mercy Mwangangi, Chief Administrative Secretary of the Ministry of Health, said the single-shot Johnson and Johnson vaccine are easily stored and have a longer shelf life. The vaccines therefore require fewer logistics and operational cost.

“The Johnson and Johnson vaccines we have received today will ensure that Kenyans are fully vaccinated quickly. This is a road map towards having local manufacturing of vaccines in Africa,” said Ms Mwangangi, adding that the Ministry of Health will prioritize the distribution of Johnson and Johnson vaccines towards the primary health care level.

“The vaccines are of great utility particularly in reaching primary health care level of our health system where uptake of vaccines is low.”

She said the single dose vaccine will ensure this population is vaccinated quickly, considering the mobile nature of the different population to ensure they are covered as we fight against the Covid 19.

Stephen Karingi, Director, Regional Integration and Trade Division of the Economic Commission for Africa who was at the airport with the Kenyan government officials and AVAT Strategic Partners (Africa Centres for Disease Control and Prevention and Afreximbank) to receive the vaccines said, “this is a big moment for the continent as we are witnessing the country’s efforts to protect its citizens by securing vaccines made in Africa for Africans.”

“It is a demonstration that African countries can indeed pool their resources together and manufacture essential medicines and vaccines for themselves and at the same time create market for it. This is a confirmation that local production of vaccines and pooled procurement of pharmaceutical products are possible as envisaged in the African Continental Free Trade Area (AfCFTA),” said Mr Karingi.

If fully implemented, he said, the AfCFTA will provide African countries with an opportunity to boost local production of pharmaceutical products like these vaccines and end the continent’s over dependence on imported medicines and vaccines.

According to AVAT, with the 141,600 vaccines delivered today, we hope to continue the efforts toward increasing the number of fully vaccinated persons, while expediting efforts towards the delivery of additional doses to Kenya and the wider African continent

“As vaccines become available, we encourage governments to avail them to as many people as possible while imploring each and every individual to get vaccinated with any and all available vaccines as guided by the Ministry of Health while continuing to observe the set guidelines by the ministry of health,” said AVAT in a press statement.

On August 5, South African President Cyril Ramaphosa, announced that the African Union (AU) would start monthly shipments of vaccines acquired by the AVAT to the AU Member States.

The agreement with Johnson & Johnson was made possible through a $2 billion facility provided by the African Export-Import Bank (Afreximbank).

The AVAT initiative is a partnership between the AU Africa Centres for Disease Control and Prevention (Africa CDC), the African Export-Import Bank (Afreximbank) and the United Nations Economic Commission for Africa (UNECA).

Monthly shipments of the Johnson and Johnson vaccines will continue with a target of delivering almost 50m vaccines before the end of December. It is expected that by January 2022, the number of vaccines being released will be in excess of 25m per month.

Through AVAT African Member States collectively purchased 400 million vaccines to safeguard the health of the African population against Covid 19.

The AU expects to immunize a third of the African people and bring Africa halfway towards its continental goal of vaccinating at least 60 per cent of the population.

Issued by:

Communications Section Economic Commission for Africa PO Box 3001 Addis Ababa Ethiopia Tel: +251 11 551 5826 E-mail: eca-info@un.org